Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy
The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
X-linked adrenoleukodystrophy (X-ALD) is a fatal neurodegenerative disorder, characterized by progressive cerebral demyelination cerebral childhood adrenoleukodystrophy (CCALD) or spinal cord neurodegeneration (adrenomyeloneuropathy, AMN), adrenal insufficiency and accumulation of very long-chain fatty acids (VLCFA) in tissues. The disease is caused by mutations in the ABCD1 gene, which encodes a peroxisomal transporter that plays a role in the import of VLCFA or VLCFA-CoA into peroxisomes. The Abcd1 knockout mice develop a spinal cord disease that mimics AMN in adult patients, with late onset at 20 months of age. The mechanisms underlying cerebral demyelination or axonal degeneration in spinal cord are unknown. Here, we present evidence by gas chromatography/mass spectrometry that malonaldehyde-lysine, a consequence of lipoxidative damage to proteins, accumulates in the spinal cord of Abcd1 knockout mice as early as 3.5 months of age. At 12 months, Abcd1- mice accumulate additional proteins modified by oxidative damage arising from metal-catalyzed oxidation and glycoxidation/lipoxidation. While we show that VLCFA excess activates enzymatic antioxidant defenses at the protein expression levels, both in neural tissue, in ex vivo organotypic spinal cord slices from Abcd1- mice, and in human ALD fibroblasts, we also demonstrate that the loss of Abcd1 gene function hampers oxidative stress homeostasis. We find that the alpha-tocopherol analog Trolox is able to reverse oxidative lesions in vitro, thus providing therapeutic hope. These results pave the way for the identification of therapeutic targets that could reverse the deregulated response to oxidative stress in X-ALD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, supraphysiological accumulation of C26:0 in astrocytes of ABCD1-deficient mice is followed by production of high reactive oxygen species (15, 16).”
From X-linked adrenoleukodystrophy and primary adrenal insufficiency (2023) · cites this paper as [15]
In the citing paper
“Interestingly, Abcd1 knockout mice display oxidative damage to proteins in the spinal cord already at the age of 3 months [39], long before the first neuropathological lesions in the spinal cord at around 16 months of age and clinical signs at 20 months of age [40].”
From X-linked adrenoleukodystrophy: Clinical, metabolic, genetic and pathophysiological aspects (2012) · cites this paper as [39]
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455 · cited 1×
“Oxidative stress is a common finding to a growing number of neurodegenerative diseases, although its role as causative factor needs still to be ascertained for most of them (12).”
BackgroundWang, H., & Joseph, J. A. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00107-0 · Cited by 2,346 · cited 2×
“Intracellular ROS levels were estimated using the ROSsensitive H2DCFDA probe as described (27,61).”
MethodHalliwell, B., & Whiteman, M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705776 · Cited by 2,238
Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W. (2006) · Science · doi:10.1126/science.1123511 · Cited by 1,623 · cited 1×
“It is tempting to speculate about a scenario comparable with ALS, in which different cell types contribute to different phases of disease progression—motorneurons in early phases of disease onset and microglia in later phases (44).”
ResultInoguchi, T., Li, P., Umeda, F., Yu, H. Y., Kakimoto, M., Imamura, M., Aoki, T., Etoh, T., Hashimoto, T., Naruse, M., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1939 · Cited by 1,577 · cited 1×
“Indeed, a few examples of fatty acids producing ROS via extramitochondrial sources include: (i) the saturated palmitic acid involving activation of NAD(P)H oxidase (47); (ii) arachidonic acid conversion via lipoxygenase (48,49); (iii) the degradation of VLCFA in peroxisomes, which could account for a part of observed…”
BackgroundLocalization of mitochondria in living cells with rhodamine 123.
Johnson, L. V., Walsh, M. L., & Chen, L. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.2.990 · Cited by 1,553
Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters
Mosser, J., Douar, A.-M., Sarde, C.-O., Kioschis, P., Feil, R., Moser, H., Poustka, A.-M., Mandel, J.-L., & Aubourg, P. (1993) · Nature · doi:10.1038/361726a0 · Cited by 1,202 · cited 2×
“The disease is caused by mutations in the ALD gene (official nomenclature ABCD1) that lead to loss of function of the ALD protein (ALDP) (2).”
BackgroundVivekananthan, D. P., Penn, M. S., Sapp, S. K., Hsu, A., & Topol, E. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13637-9 · Cited by 1,083
Mitochondrial Membrane Potential in Living Cells
Chen, L. B. (1988) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.04.110188.001103 · Cited by 1,037 · cited 1×
“takes benefit of the differential membrane potential to get selectively accumulated in mitochondria (29).”
Background
Cited by
Engelen, M., Kemp, S., de Visser, M., van Geel, B. M., Wanders, R. J., Aubourg, P., & Poll-The, B. (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-51 · Cited by 562
“In vivo, VLCFA cause oxidative stress and oxidative damage to proteins [64,65] microglial activation and apoptosis [66].”
Self-citationMyelin Proteomics: Molecular Anatomy of an Insulating Sheath
Jahn, O., Tenzer, S., & Werner, H. B. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8071-2 · Cited by 329
“Decreased plasmalogen levels [45, 46] and increased levels of reactive oxygen species [47, 48] may also contribute to the demyelination in X-linked adrenoleukodystrophy caused by the mutated peroxisomal transporter ABCD1, suggesting that a normal plasmalogen metabolism may prevent peroxisomal- and myelin-related disea…”
BackgroundX-linked adrenoleukodystrophy: Clinical, metabolic, genetic and pathophysiological aspects
Kemp, S., Berger, J., & Aubourg, P. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.03.012 · Cited by 283
“play oxidative damage to proteins in the spinal cord already at the age of 3 months [39], long before the first neuropathological lesions”
Self-citationThe peroxisome: an update on mysteries 2.0
Islinger, M., Voelkl, A., Fahimi, H. D., & Schrader, M. (2018) · Histochemistry and Cell Biology · doi:10.1007/s00418-018-1722-5 · Cited by 283
The peroxisome: an update on mysteries
Islinger, M., Grille, S., Fahimi, H. D., & Schrader, M. (2012) · Histochemistry and Cell Biology · doi:10.1007/s00418-012-0941-4 · Cited by 281
“These were accompanied by increased oxidatively damaged proteins implying that the accumulating VLCFA induce increasing ROS concentrations potentially by modifying the mitochondrial inner membrane potential (Fourcade et al. 2008; Galino et al. 2011).”
BackgroundAdrenoleukodystrophy—Neuroendocrine pathogenesis and redefinition of natural history
Kemp, S., Huffnagel, I. C., Linthorst, G. E., Wanders, R. J., & Engelen, M. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.90 · Cited by 275
Self-citationReactive oxygen species and peroxisomes: Struggling for balance
Bonekamp, N. A., Völkl, A., Fahimi, H. D., & Schrader, M. (2009) · BioFactors · doi:10.1002/biof.48 · Cited by 274
“[72] have recently investigated the relation between oxidative lesions and neurodegeneration in an ABCD1 knock-out model, although the mouse model rather reproduces a milder AMN phenotype of ALD.”
Pathophysiology of X-linked adrenoleukodystrophy
Berger, J., Forss-Petter, S., & Eichler, F. S. (2014) · Biochimie · doi:10.1016/j.biochi.2013.11.023 · Cited by 238
“In addition, an activation of anti-oxidative responses was observed in organotypic spinal cord slices of Abcd1-deficient mice after exposure to exogenous VLCFA [53].”
BackgroundInfluentialPeroxisome‐mitochondria interplay and disease
Schrader, M., Costello, J., Godinho, L. F., & Islinger, M. (2015) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-015-9819-7 · Cited by 215
Redox interplay between mitochondria and peroxisomes
Lismont, C., Nordgren, M., Van Veldhoven, P. P., & Fransen, M. (2015) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00035 · Cited by 214
Turk, B. R., Theda, C., Fatemi, A., & Moser, A. B. (2020) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10003 · Cited by 210
“This experimental data led to the antioxidant trial in AMN patients (Fourcade et al., 2008).”
BackgroundMethodInfluentialDicer ablation in oligodendrocytes provokes neuronal impairment in mice
Shin, D., Shin, J., McManus, M. T., Ptáček, L. J., & Fu, Y. (2009) · Annals of Neurology · doi:10.1002/ana.21927 · Cited by 208
Peroxisomes in brain development and function
Berger, J., Dorninger, F., Forss-Petter, S., & Kunze, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.12.005 · Cited by 194
“Interestingly, lipoxidative damagewas observed early (at threemonths of age) in the spinal cord of Abcd1-deficient mice, long before the onset of any neuropathological or motoric abnormalities were detected [160].”
BackgroundX-Linked Adrenoleukodystrophy: Pathogenesis and Treatment
Engelen, M., Kemp, S., & Poll-The, B.-T. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0486-0 · Cited by 187
Self-citationPeroxisomal ABC transporters: Structure, function and role in disease
Morita, M., & Imanaka, T. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.02.009 · Cited by 183
The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy
Ofman, R., Dijkstra, I. M. E., van Roermund, C. W. T., Burger, N., Turkenburg, M., van Cruchten, A., van Engen, C. E., Wanders, R. J. A., & Kemp, S. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000061 · Cited by 170
“90 The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy”
BackgroundSelf-citationPeroxisomes, lipid metabolism and lipotoxicity
Wanders, R. J. A., Ferdinandusse, S., Brites, P., & Kemp, S. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.01.001 · Cited by 169
Self-citationStępień, K. M., Heaton, R. A., Rankin, S., Murphy, A., Bentley, J., Sexton, D. W., & Hargreaves, I. P. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6070071 · Cited by 168
Marquez, B., & Van Bambeke, F. (2011) · Current Drug Targets · doi:10.2174/138945011795378504 · Cited by 165
Antioxidants halt axonal degeneration in a mouse model of X‐adrenoleukodystrophy
López‐Erauskin, J., Fourcade, S., Galino, J., Ruiz, M., Schlüter, A., Naudi, A., Jove, M., Portero‐Otin, M., Pamplona, R., Ferrer, I., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22363 · Cited by 135
“The source of this oxidative damage is possibly related to the excess of saturated and unsaturated VLCFA, shown to generate both free radicals and oxidative damage to proteins in vitro.(20,21) In the present study, we set out to test the potential of 3 well-known antioxidants, a-tocopherol, N-acetylcysteine (NAC), and…”
BackgroundMethodResultInfluentialSelf-citationPathomechanisms underlying X-adrenoleukodystrophy: A three-hit hypothesis
Singh, I., & Pujol, A. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00392.x · Cited by 148
“These conclusions are supported by the following observations: (i) loss of ABCD1 function in cultured astrocytes (56) and in the X-ALD mouse lead to excessive accumulation of VLCFA and increased oxidative stress/damage (17, 46, 52); (ii) red blood cells and white matter samples of X-ALD patients contain decreased leve…”
BackgroundResultInfluentialSelf-citationPeroxisomes in Immune Response and Inflammation
Di Cara, F., Andreoletti, P., Trompier, D., Vejux, A., Bülow, M. H., Sellin, J., Lizard, G., Cherkaoui-Malki, M., & Savary, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163877 · Cited by 128
“, SOD1, SOD2) were downregulated in both the cortex and the spinal cord [99].”
BackgroundGeneral aspects and neuropathology of X-linked adrenoleukodystrophy
Ferrer, I., Aubourg, P., & Pujol, A. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00390.x · Cited by 139
“5 months, long before the first neuropathological lesions in the spinal cord at around 16 months of age and clinical signs at 20 months of age (44).”
BackgroundSelf-citationNeuron-Oligodendrocyte Interactions in the Structure and Integrity of Axons
Duncan, G. J., Simkins, T. J., & Emery, B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.653101 · Cited by 125
“As a consequence, there is an accumulation of VLCFA in cells leading to increased oxidative stress culminating in myelin loss as well as progressive axonal degeneration (Powers et al., 2000; Fourcade et al., 2008).”
BackgroundThe Advanced Lipoxidation End-Product Malondialdehyde-Lysine in Aging and Longevity
Jové, M., Mota‐Martorell, N., Pradas, I., Martin‐Garí, M., Ayala, V., & Pamplona, R. (2020) · Antioxidants · doi:10.3390/antiox9111132 · Cited by 129
Self-citationN-acetylcysteine Pharmacology and Applications in Rare Diseases—Repurposing an Old Antioxidant
Sahasrabudhe, S. A., Terluk, M. R., & Kartha, R. V. (2023) · Antioxidants · doi:10.3390/antiox12071316 · Cited by 128
Baarine, M., Andreoletti, P., Athias, A., Nury, T., Zarrouk, A., Ragot, K., Véjux, A., Riedinger, J., Kattan, Z., Bessède, G., et al. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.03.058 · Cited by 127
“Moreover, there are also evidences that ABCD1 loss of function is correlated with defective stress homeostasis (Fourcade et al., 2008).”
InfluentialLópez-Erauskin, J., Galino, J., Ruiz, M., Cuezva, J. M., Fabregat, I., Cacabelos, D., Boada, J., Martínez, J., Ferrer, I., Pamplona, R., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt186 · Cited by 125
“Using the probe carboxy-H2DCFDA (dichlorofluorescein), which detects reactive oxygen species (ROS) of any intracellular origin, we formerly reported that an excess of C26:0 produced oxidative lesions in proteins and generated ROS (14).”
BackgroundInfluentialSelf-citationBiochemical aspects of X-linked adrenoleukodystrophy
Kemp, S., & Wanders, R. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00391.x · Cited by 116
“In addition, C26:0 accumulation results in oxidative stress (21) and both the adrenal cortex and brain of X-ALD patients show evidence of oxidative stress and oxidative damage particularly from lipid peroxidation (60).”
BackgroundSelf-citationFatty Acids - Induced Lipotoxicity and Inflammation
Savary, S., Trompier, D., Andreoletti, P., Le Borgne, F., Demarquoy, J., & Lizard, G. (2012) · Current Drug Metabolism · doi:10.2174/138920012803762729 · Cited by 111
Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy
Fourcade, S., Ruiz, M., Guilera, C., Hahnen, E., Brichta, L., Naudi, A., Portero-Otín, M., Dacremont, G., Cartier, N., Wanders, R., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq082 · Cited by 100
“In a mouse model of X-ALD, in which we observe an ‘AMN-like’ phenotype (20,21), we have demonstrated oxidative damage to proteins in the spinal cord (31).”
BackgroundMethodInfluentialSelf-citationGalea, E., Launay, N., Portero-Otin, M., Ruiz, M., Pamplona, R., Aubourg, P., Ferrer, I., & Pujol, A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.02.005 · Cited by 108
Self-citationGene therapy for leukodystrophies
Biffi, A., Aubourg, P., & Cartier, N. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr142 · Cited by 94
“Oxidative damage can be seen as early as 3 months of age in the spinal cord of ALD mice, before the onset of any neuropathological or motor abnormalities (43).”
BackgroundRedox Signaling from and to Peroxisomes: Progress, Challenges, and Prospects
Fransen, M., & Lismont, C. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2018.7515 · Cited by 80
“As already extensively explained above, genetic defects in peroxisome function often cause mitochondrial dysfunction and oxidative stress, in turn contributing to neuronal cell death (38, 51, 104, 160).”
Aging, Age-Related Diseases and Peroxisomes
Fransen, M., Nordgren, M., Wang, B., Apanasets, O., & Veldhoven, P. P. V. (2013) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-6889-5_3 · Cited by 110
Current and Future Pharmacological Treatment Strategies in X‐Linked Adrenoleukodystrophy
Berger, J., Pujol, A., Aubourg, P., & Forss‐Petter, S. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00393.x · Cited by 90
“There is also growing evidence that oxidative stress contributes to the pathogenesis of X-ALD and that excess of VLCFAs plays a role in this process (29, 41, 81).”
BackgroundSelf-citationNeurochemistry and the non-motor aspects of PD
Ferrer, I., López-Gonzalez, I., Carmona, M., Dalfó, E., Pujol, A., & Martínez, A. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.10.019 · Cited by 87
“Of note, this disease is directly caused by the accumulation of saturated very long chain fatty acids and the ensuing oxidative damage this excess generates in the cels (Ferrer et al., 2010; Fourcade et al., 2008; LópezErauskin et al., 2011).”
BackgroundSelf-citationLópez-Erauskin, J., Galino, J., Bianchi, P., Fourcade, S., Andreu, A. L., Ferrer, I., Muñoz-Pinedo, C., & Pujol, A. (2012) · Brain · doi:10.1093/brain/aws292 · Cited by 87
“However, oxidative damage to proteins appears early, 3 months of age (Fourcade et al., 2008).”
BackgroundMethodInfluentialSelf-citationSchönfeld, P., & Reiser, G. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.03.018 · Cited by 99
“According to that an excess level of C26:0 initiates enhanced ROS generation, and this finding has been hypothesized to be the cause of an earlyonset oxidative damage in the pathogenesis of an Abcd1-/- mouse model (Fourcade et al., 2008, 2014, 2015).”
Galino, J., Ruiz, M., Fourcade, S., Schlüter, A., López-Erauskin, J., Guilera, C., Jove, M., Naudi, A., García-Arumí, E., Andreu, A. L., et al. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3877 · Cited by 85
“Earlier, we reported that the levels of lipoxidative (MDAL), glycoxidative/lipoxidative (CEL, CML), and protein oxidative (GSA; AASA) markers were about doubled in the fibroblasts derived from patients with X-ALD (20).”
InfluentialSelf-citationPlasmalogen deficiency in cerebral adrenoleukodystrophy and its modulation by lovastatin
Khan, M., Singh, J., & Singh, I. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05513.x · Cited by 85
“Reactive lipid aldehyde adduct (malondialdehyde-lysine) are also observed in the spinal cords of these mice (Fourcade et al. 2008).”
BackgroundOxidative stress and adrenocortical insufficiency
Prasad, R., Kowalczyk, J. C., Meimaridou, E., Storr, H. L., & Metherell, L. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0346 · Cited by 96
“Increased ROS production, depletion of GSH and decreased mitochondrial membrane potential in patient dermal fibroblasts have been described (Fourcade et al. 2008).”
BackgroundBrain endothelial dysfunction in cerebral adrenoleukodystrophy
Musolino, P. L., Gong, Y., Snyder, J. M. T., Jimenez, S., Lok, J., Lo, E. H., Moser, A. B., Grabowski, E. F., Frosch, M. P., & Eichler, F. S. (2015) · Brain · doi:10.1093/brain/awv250 · Cited by 92
“Previous observations have implicated VLCFA elevations in oxidative stress and the axonopathy seen in the ABCD1 knockout mouse (Fourcade et al., 2008; Galea et al., 2012).”
BackgroundAubourg, P. R., & Wanders, R. J. A. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59565-2.00028-9 · Cited by 94
Partial rescue of Rett syndrome by ω-3 polyunsaturated fatty acids (PUFAs) oil
Felice, C. D., Signorini, C., Durand, T., Ciccoli, L., Leoncini, S., D’Esposito, M., Filosa, S., Oger, C., Guy, A., Bultel‐Poncé, V., et al. (2012) · Genes & Nutrition · doi:10.1007/s12263-012-0285-7 · Cited by 90
“Interestingly, evidence of early O.S.-driven damage has been reported also in X-ALD (Fourcade et al. 2008; Galino et al. 2011), as well as improvement of clinical symptoms in the patients (Kawashima et al. 2011), and halting of axonal degeneration in an X-ALD mouse model following treatment with antioxidants (López-E…”
BackgroundZarrouk, A., Vejux, A., Nury, T., El Hajj, H. I., Haddad, M., Cherkaoui-Malki, M., Riedinger, J.-M., Hammami, M., & Lizard, G. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/623257 · Cited by 79
“This mitochondrial disturbance was also observed on rat C6 glioma cells, murine oligodendrocytes 158 N [34], normal fibroblasts, and fibroblasts of X-ALD patients [55] as well as oligodendrocytes and astrocytes of rat brain [33] treated with C24:0 or C26:0 used at 20 μM and higher, indicating that a decrease of ΔΨm is…”
BackgroundPioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy
Morató, L., Galino, J., Ruiz, M., Calingasan, N. Y., Starkov, A. A., Dumont, M., Naudí, A., Martínez, J. J., Aubourg, P., Portero-Otín, M., et al. (2013) · Brain · doi:10.1093/brain/awt143 · Cited by 82
“5 months of age, which is 41 year before the neuropathological and neurological signs of the disease appear (at 15 and 20 months of age, respectively) (Fourcade et al., 2008).”
InfluentialSelf-citationNury, T., Zarrouk, A., Ragot, K., Debbabi, M., Riedinger, J., Véjux, A., Aubourg, P. R., & Lizard, G. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.03.037 · Cited by 91
“In agreement with previous studies, our results support the hypothesis that oxidative stress is involved in the pathophysiology of X-ALD [62,68].”
BackgroundResultInfluentialFourcade, S., Ferrer, I., & Pujol, A. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.041 · Cited by 76
Self-citationCimini, A., Moreno, S., D'Amelio, M., Cristiano, L., D'Angelo, B., Falone, S., Benedetti, E., Carrara, P., Fanelli, F., Cecconi, F., et al. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1199 · Cited by 68
“Accordingly, mouse models of brain peroxisome biogenesis disorders show decreased plasmalogen and docosahexaenoic acid (DHA) levels,altered cholesterol homeostasis, very long chain fatty acids accumulation, and oxidative damage [21–24].”
Mitochondrial dysfunction in central nervous system white matter disorders
Morató, L., Bertini, E., Verrigni, D., Ardissone, A., Ruíz, M., Ferrer, I., Uziel, G., & Pujol, A. (2014) · Glia · doi:10.1002/glia.22670 · Cited by 81
“VLCFAs can interfere with OXPHOS proteins and mitochondria respiration, increasing ROS production (Fourcade et al., 2008; Lopez-Erauskin et al., 2013b).”
BackgroundSelf-citationHow the brain fights fatty acids’ toxicity
Schönfeld, P., & Reiser, G. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105050 · Cited by 78
Adenoassociated virus serotype 9-mediated gene therapy for x-linked adrenoleukodystrophy
Gong, Y., Mu, D., Prabhakar, S., Moser, A., Musolino, P., Ren, J., Breakefield, X. O., Maguire, C. A., & Eichler, F. S. (2015) · Molecular Therapy · doi:10.1038/mt.2015.6 · Cited by 74
Hartley, M. D., Kirkemo, L. L., Banerji, T., & Scanlan, T. S. (2017) · Endocrinology · doi:10.1210/en.2016-1842 · Cited by 70
Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy
Schlüter, A., Espinosa, L., Fourcade, S., Galino, J., López, E., Ilieva, E., Morató, L., Asheuer, M., Cook, T., McLaren, A., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr536 · Cited by 72
“Previous studies from our laboratory demonstrate that oxidative stress contributes to the progression of X-ALD (11,22,24,25).”
BackgroundMethodInfluentialSelf-citationPeroxisomal ABC Transporters: An Update
Tawbeh, A., Gondcaille, C., Trompier, D., & Savary, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116093 · Cited by 68
Launay, N., Ruiz, M., Grau, L., Ortega, F. J., Ilieva, E. V., Martínez, J. J., Galea, E., Ferrer, I., Knecht, E., Pujol, A., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1655-9 · Cited by 62
“Using this mouse model and patient samples, studies by our laboratory and others have revealed that VLCFA-induced oxidative stress is an early, key pathogenic factor in X-ALD [29, 31, 35, 57, 73, 74, 85, 94], although the exact mechanisms by which oxidative stress causes neurodegeneration in X-ALD are not entirely cle…”
BackgroundSelf-citationTreatment of cerebral adrenoleukodystrophy: allogeneic transplantation and lentiviral gene therapy
Gupta, A. O., Raymond, G., Pierpont, E. I., Kemp, S., McIvor, R. S., Rayannavar, A., Miller, B., Lund, T. C., & Orchard, P. J. (2022) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2022.2124857 · Cited by 67
“a role in the pathophysiology of progression in cerebral disease [52,53], interventions such as N-acetylcysteine were explored.”
BackgroundSelf-citationBottelbergs, A., Verheijden, S., Van Veldhoven, P. P., Just, W., Devos, R., & Baes, M. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-61 · Cited by 66
“In fact, in patients with ABCD1 deficiency, lipid peroxidation in plasma was higher in the AMN phenotype than in cerebral ALD and in asymptomatic patients [48].”
BackgroundRönicke, S., Kruska, N., Kahlert, S., & Reiser, G. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.08.005 · Cited by 62
Peroxisomes, myelination, and axonal integrity in the CNS
Baes, M., & Aubourg, P. (2009) · The Neuroscientist · doi:10.1177/1073858409336297 · Cited by 65
Adrenoleukodystrophy in female heterozygotes: underrecognized and undertreated
Jangouk, P., Zackowski, K. M., Naidu, S., & Raymond, G. V. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.11.001 · Cited by 63
Gallego‐Villar, L., Rivera‐Barahona, A., Cuevas-Martín, C., Guenzel, A. J., Pérez, B., Barry, M. A., Murphy, M. P., Logan, A., González-Quintana, A., Martín, M. A., et al. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.007 · Cited by 63
Aberrant regulation of the GSK ‐3β/ NRF 2 axis unveils a novel therapy for adrenoleukodystrophy
Ranea‐Robles, P., Launay, N., Ruiz, M., Calingasan, N. Y., Dumont, M., Naudí, A., Portero‐Otín, M., Pamplona, R., Ferrer, I., Beal, M. F., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708604 · Cited by 55
“AASA, CML, CEL, and MDAL concentrations in total proteins from spinal cord homogenates were measured by gas chromatography/ ª 2018 The Authors EMBO Molecular Medicine 10: e8604 | 2018 11 of 16 mass spectrometry (GC/MS), as reported (Fourcade et al, 2008).”
InfluentialSelf-citationLeukodystrophies with late disease onset: an update
Köhler, W. (2010) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328338313a · Cited by 58
Autophagy induction halts axonal degeneration in a mouse model of X-adrenoleukodystrophy
Launay, N., Aguado, C., Fourcade, S., Ruiz, M., Grau, L., Riera, J., Guilera, C., Giròs, M., Ferrer, I., Knecht, E., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-014-1378-8 · Cited by 51
“The data showed signs of oxidative damage in spinal cords from the X-ALD mouse model and in fibroblasts from X-ALD patients with direct oxidative, glycoxidative and lipoxidative damage to proteins, as well as altered enzymatic antioxidant defenses [17].”
BackgroundMethodSelf-citationBaarine, M., Ragot, K., Genin, E. C., El Hajj, H., Trompier, D., Andreoletti, P., Ghandour, M. S., Menetrier, F., Cherkaoui‐Malki, M., Savary, S., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06311.x · Cited by 51
“In addition, as the mitochondrial and redox status can be modified in the case of ABCD1 deficiency and/or VLCFA accumulation (Fourcade et al. 2008; Hein et al. 2008), mitochondrial activity and content as well as redox status were measured by flow cytometry.”
BackgroundKruska, N., Schönfeld, P., Pujol, A., & Reiser, G. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.01.005 · Cited by 56
Self-citationLaunay, N., Ruiz, M., Fourcade, S., Schlüter, A., Guilera, C., Ferrer, I., Knecht, E., & Pujol, A. (2013) · Brain · doi:10.1093/brain/aws370 · Cited by 47
Self-citationFourcade, S., López-Erauskin, J., Ruiz, M., Ferrer, I., & Pujol, A. (2014) · Biochimie · doi:10.1016/j.biochi.2013.09.012 · Cited by 55
Self-citationMicroglial dysfunction as a key pathological change in adrenomyeloneuropathy
Gong, Y., Sasidharan, N., Laheji, F., Frosch, M., Musolino, P., Tanzi, R., Kim, D. Y., Biffi, A., El Khoury, J., & Eichler, F. (2017) · Annals of Neurology · doi:10.1002/ana.25085 · Cited by 54
“Although the development of AMN occurs in the absence of overt inflammation, early oxidative damage including increased oxidative lesions and altered antioxidant defense is detected in the mouse spinal cord and human fibroblast cell lines.(46) As the well-known inducer of phosphatidylserine exposure, oxidative stress…”
Verheijden, S., Bottelbergs, A., Krysko, O., Krysko, D. V., Beckers, L., De Munter, S., Van Veldhoven, P. P., Wyns, S., Kulik, W., Nave, K.-A., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.06.006 · Cited by 54
“Accumulation of VLCFA has been implicated as the pathogenic inducer, causing oxidative stress and alterations in energy homeostasis (Fourcade et al., 2008; Galino et al., 2011).”
BackgroundTherapy of X-linked adrenoleukodystrophy
Semmler, A., Köhler, W., Jung, H. H., Weller, M., & Linnebank, M. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.9.1367 · Cited by 50
“Recently, it was shown that elevated VLCFA are highly toxic to brain cells due to mitochondrial dysfunction [42] or impairment of oxidative stress homeostasis [43].”
BackgroundLee, C. A. A., Seo, H. S., Armien, A. G., Bates, F. S., Tolar, J., & Azarin, S. M. (2018) · Fluids and Barriers of the CNS · doi:10.1186/s12987-018-0094-5 · Cited by 52
Ruiz, M., Jové, M., Schlüter, A., Casasnovas, C., Villarroya, F., Guilera, C., Ortega, F. J., Naudí, A., Pamplona, R., Gimeno, R., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv375 · Cited by 45
“6A–C), very early in life at 3 months of age, when first signs of lipo-oxidative damage (MDAL) appear (58).”
BackgroundSelf-citationBaarine, M., Beeson, C., Singh, A. K., & Singh, I. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.12992 · Cited by 52
“Reduced mitochondrial DNA and mitochondrial protein levels were also reported in the white matter of autopsy brain from patients with X-linked adrenoleukodystrophy (Fourcade et al. 2008; Singh and Pujol 2010; LopezErauskin et al. 2012; Morato et al. 2013).”
InfluentialGlutathione imbalance in patients with X-linked adrenoleukodystrophy
Petrillo, S., Piemonte, F., Pastore, A., Tozzi, G., Aiello, C., Pujol, A., Cappa, M., & Bertini, E. (2013) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2013.05.009 · Cited by 45
“Oxidative damage has also been evidenced in skin-derived fibroblasts [9,26], plasma [27,28] and lymphoblasts [29], thus implying that oxidative stress may represent a systemic phenomenon linked to the loss of function of the ABCD1 transporter/ALD protein.”
BackgroundResultInfluentialSelf-citationFourcade, S., Morató, L., Parameswaran, J., Ruíz, M., Ruiz-Cortés, Z. T., Jové, M., Naudí, A., Martínez‐Redondo, P., Dierssen, M., Ferrer, I., et al. (2017) · Aging Cell · doi:10.1111/acel.12682 · Cited by 51
“…semialdehyde), CEL (N2-(carboxyethyl)-lysine), CML (N2-(carboxymethyl)-lysine), and MDAL (N2-malondialdehyde-lysine) GSA, AASA, CEL, CML, and MDAL concentrations in total proteins from spinal cord homogenates were measured by gas chromatography/mass spectrometry (GC/MS) (Fourcade et al., 2008).”
BackgroundMethodSelf-citationLipid-induced endoplasmic reticulum stress in X-linked adrenoleukodystrophy
van de Beek, M.-C., Ofman, R., Dijkstra, I. M. E., Wijburg, F. A., Engelen, M., Wanders, R. J. A., & Kemp, S. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.06.003 · Cited by 54
Self-citationLipidomic biomarkers in plasma correlate with disease severity in adrenoleukodystrophy
Jaspers, Y. R. J., Yska, H. A. F., Bergner, C. G., Dijkstra, I. M. E., Huffnagel, I. C., Voermans, M. M. C., Wever, E. J. M., Salomons, G. S., Vaz, F. M., Jongejan, A., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00605-9 · Cited by 50
Self-citationKhan, M., Singh, J., Gilg, A. G., Uto, T., & Singh, I. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m002329 · Cited by 49
ABCD1 dysfunction alters white matter microvascular perfusion
Lauer, A., Da, X., Hansen, M. B., Boulouis, G., Ou, Y., Cai, X., Liberato Celso Pedrotti, A., Kalpathy-Cramer, J., Caruso, P., Hayden, D. L., et al. (2017) · Brain · doi:10.1093/brain/awx262 · Cited by 48
“Moreover, in CALD mitochondrial dysfunction and increased oxidative stress derived from accumulation of VLCFA due to loss of ABCD1 function (Fourcade et al., 2008; Berger et al., 2014) may contribute to the selective spatial and temporal microvascular flow deregulation we observed in NAWM of…”
BackgroundC26:0-Carnitine Is a New Biomarker for X-Linked Adrenoleukodystrophy in Mice and Man
van de Beek, M.-C., Dijkstra, I. M. E., van Lenthe, H., Ofman, R., Goldhaber-Pasillas, D., Schauer, N., Schackmann, M., Engelen-Lee, J.-Y., Vaz, F. M., Kulik, W., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0154597 · Cited by 48
“Long before the first neuropathological lesions are detectable in the spinal cord of Abcd1 knockout mice there is oxidative damage to proteins [23].”
BackgroundSelf-citationCasasnovas, C., Ruíz, M., Schlüter, A., Naudí, A., Fourcade, S., Veciana, M., Castañer, S., Albertí, A., Bargalló, N., Johnson, M. R., et al. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00735-2 · Cited by 47
Self-citationStrachan, L. R., Stevenson, T. J., Freshner, B., Keefe, M. D., Miranda Bowles, D., & Bonkowsky, J. L. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx249 · Cited by 46
Haynes, C. A., & De Jesús, V. R. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.03.026 · Cited by 46
“The mechanism(s) by which VLCFA accumulation leads to the CNS demyelination lesion characteristic of X-ALD is an active area of research, and the involvement of pro-inflammatory cytokines [11,12] and oxidative stress [13–15] in CNS neurons has been reported.”
Oxidative Imbalance in Nonstimulated X-Adrenoleukodystrophy-Derived Lymphoblasts
Uto, T., Contreras, M. A., Gilg, A. G., & Singh, I. (2008) · Developmental Neuroscience · doi:10.1159/000191212 · Cited by 42
“and signs of oxidative stress in the spinal cord during adulthood [”
BackgroundMetabolic rerouting via SCD1 induction impacts X-linked adrenoleukodystrophy
Raas, Q., van de Beek, M.-C., Forss-Petter, S., Dijkstra, I. M. E., Deschiffart, A., Freshner, B. C., Stevenson, T. J., Jaspers, Y. R. J., Nagtzaam, L., Wanders, R. J. A., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142500 · Cited by 40
“In human fibroblasts, SCD1 activation increases the ratio of monounsaturated to saturated VLCFA; our work and that of others shows that exposure of saturated VLCFA to ALD cells causes oxidative stress, mitochondrial dysfunction, and an increase in the ER stress response (23, 25, 27, 28, 52).”
BackgroundSelf-citationBaarine, M., Ragot, K., Athias, A., Nury, T., Kattan, Z., Genin, E. C., Andreoletti, P., Ménétrier, F., Riedinger, J.-M., Bardou, M., et al. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2011.10.007 · Cited by 43
Terluk, M. R., Tieu, J., Sahasrabudhe, S. A., Moser, A. B., Watkins, P. A., Raymond, G. V., & Kartha, R. V. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01226-7 · Cited by 39
“While the precise mechanism leading to cerebral disease is uncertain, there is strong evidence that the saturated VLCFA accumulation resulting from dysfunctional peroxisomal proteins induces cellular apoptosis and mitochondrial dysregulation and this leads to progressive demyelination [4, 6, 7, 27].”
BackgroundSingh, J., Khan, M., & Singh, I. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m017491 · Cited by 37
Functional Characterization of IPSC-Derived Brain Cells as a Model for X-Linked Adrenoleukodystrophy
Baarine, M., Khan, M., Singh, A., & Singh, I. (2015) · PLOS ONE · doi:10.1371/journal.pone.0143238 · Cited by 38
Epigenomic signature of adrenoleukodystrophy predicts compromised oligodendrocyte differentiation
Schlüter, A., Sandoval, J., Fourcade, S., Díaz‐Lagares, A., Ruiz, M., Casaccia, P., Esteller, M., & Pujol, A. (2018) · Brain Pathology · doi:10.1111/bpa.12595 · Cited by 35
Self-citationZhou, J., Terluk, M. R., Orchard, P. J., Cloyd, J. C., & Kartha, R. V. (2021) · Biomedicines · doi:10.3390/biomedicines9121826 · Cited by 38
Mitochondrial Dysfunction in Demyelinating Diseases
Carvalho, K. S. (2013) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2013.09.001 · Cited by 38
Ward-Caviness, C. K., Breitner, S., Wolf, K., Cyrys, J., Kastenmüller, G., Wang‐Sattler, R., Schneider, A. E., & Peters, A. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw247 · Cited by 38
Activation of sirtuin 1 as therapy for the peroxisomal disease adrenoleukodystrophy
Morató, L., Ruíz, M., Boada, J., Calingasan, N. Y., Galino, J., Guilera, C., Jové, M., Naudí, A., Ferrer, I., Pamplona, R., et al. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.20 · Cited by 37
Self-citationManor, J., Chung, H., Bhagwat, P. K., & Wangler, M. F. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24953 · Cited by 32
“It is yet, however, to elucidate the involvement of elevated VLCFAs in the pathogenesis of XALD.”
BackgroundInfluentialMuneer, Z., Wiesinger, C., Voigtländer, T., Werner, H. B., Berger, J., & Forss-Petter, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108655 · Cited by 33
“Such perturbations may result in alterations of membrane structure, stability and function [19–21], oxidative stress [22,23], energy metabolism [24,25] and increased expression of inducible nitric oxide synthase [26,27].”
BackgroundWang, X.-M., Yik, W. Y., Zhang, P., Lu, W., Dranchak, P. K., Shibata, D., Steinberg, S. J., & Hacia, J. G. (2012) · Stem Cell Research & Therapy · doi:10.1186/scrt130 · Cited by 33
“Other hypotheses have focused on the roles of oxidative stress [12-16], myelin sheath integrity [17], oligodendrocyte apoptosis and microglial cell activation [1,2], and CNS cell membrane receptors [18].”
Background
Metadata
- Authors
- Fourcade, S., Lopez-Erauskin, J., Galino, J., Duval, C., Naudi, A., Jove, M., Kemp, S., Villarroya, F., Ferrer, I., Pamplona, R., Portero-Otin, M., & Pujol, A.
- Affiliations
- Institut d'Investigació Biomédica de Bellvitge (ES)
- Amsterdam UMC Location University of Amsterdam (NL)
- Instituto de Salud Carlos III (ES)
- Biomedical Research Networking Center on Neurodegenerative Diseases (ES)
- Universitat de Lleida (ES)
- Institució Catalana de Recerca i Estudis Avançats (ES)
- Corresponding author
- Pujol, A.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-03-04
- Volume
- 17
- Issue
- 12
- Pages
- 1762-1773
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2168163415
- Cited by
- 214
- References
- 67
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 14 · 2023: 10 · 2022: 13 · 2021: 11 · 2020: 9 · 2019: 9 · 2018: 11 · 2017: 11 · 2016: 8 · 2015: 15 · 2014: 14 · 2013: 18 · 2012: 17
- FWCI
- 8.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- X-linked adrenoleukodystrophy, ABCD1 gene, oxidative stress, lipid peroxidation, glycoxidation, very long chain fatty acids, adrenomyeloneuropathy, antioxidant defense, Trolox, oxidative protein damage
- MeSH terms
- Superoxide Dismutase 2, Adrenoleukodystrophy, Animals, Catalase, Chromans, Fatty Acids, Fibroblasts, Humans, Lysine, Malondialdehyde, Mice, Inbred C57BL, Motor Neurons, Oxidation-Reduction, Spinal Cord, Superoxide Dismutase, Oxidative Stress, Mice, Membrane Potential, Mitochondrial, Chemokine CCL22, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.